Abstract
BACKGROUND: Melanoma is the most aggressive cutaneous neoplasm, the main interventions being surgery, chemotherapy or immunotherapy. Despite advances in immune checkpoint inhibitors (ICIs), a significant proportion of patients do not respond to treatment. In a previous study by the Immuno-Oncology group at the Barretos Cancer Hospital (HCB), the CD24 and NFIL3 genes were identified as po…